, Volume 15, Issue 1, pp 23–26 | Cite as

La grippe

Phytothérapie Clinique


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Schwerdtfeger SM, Melzig MF (2008) Antiviral activity by inhibition of neuraminidase. Z Phytotherapie 29:65–70CrossRefGoogle Scholar
  2. 2.
    Hong EH, Song JH, Shim A, et al (2015) Coadministration of Hedera helix L. extract enabled mice to overcome insufficient protection against influenza A/PR/8 virus infection under suboptimal treatment with oseltamivir. Plus One 10:e0131089Google Scholar
  3. 3.
    Wen S, Huifu X, Hao H (2011) In vitro anti-influenza A H1N1 effect of extract of Bupleuri radix. Immunopharmacol Immunotoxicol 33:433–7CrossRefPubMedGoogle Scholar
  4. 4.
    Pleschka S, Stein M, Schoop R, Hudson JB (2009) Anti-viral properties and mode of action of standardized Echinacea purpurea extract against highly pathogenic avian influenza virus (H5N1, H7N7) and swine-origin H1N1 (S-OIV). Virol J 6:197CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Kalus U, Grigorov A, Kadecki O, et al (2009) Cistus incanus (CYSTUS052) for treating patients with infection of the upper respiratory tract. A prospective, randomised, placebo-controlled clinical study. Antiviral Res 84:267–71CrossRefPubMedGoogle Scholar
  6. 6.
    Steflitsch W, Steflitsch M (2007) Aromatherapie: wissenschaft–klinik–praxis. Springer Wien, New YorkCrossRefGoogle Scholar
  7. 7.
    Garozzo A, Timpanaro R, Bisignano B, et al (2009) In vitro antiviral activity of Melaleuca alternifolia essential oil. Lett Appl Microbiol 49:806–8CrossRefPubMedGoogle Scholar
  8. 8.
    Hayashi K, Imanishi N, Kashiwayama Y, et al (2007) Inhibitory effect of cinnamaldehyde, derived from Cinnamomi cortex, on the growth of influenza A/PR/8 virus in vitro and in vivo. Antiviral Res 74:1–8CrossRefPubMedGoogle Scholar

Copyright information

© Lavoisier 2017

Authors and Affiliations

  1. 1.DU de phytothérapieParis-XIIIBobigny cedexFrance

Personalised recommendations